Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis

Clinical trial NCT02869802 · RECRUITING

Trial details

NCT number: NCT02869802
Sponsor: British Columbia Cancer Agency
Status: RECRUITING
Study type: OBSERVATIONAL

Cancer Pancreatic Cancer

Start date: 2016-10-06
Primary completion: 2026-12-01
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.